Listen To The Lancet Gastroenterology & Hepatology

Matthew Akiyama (Montefiore Medical Center and Albert Einstein College of Medicine, USA) discusses a Review on hepatitis C elimination among people incarcerated in prisons.

Monika Sarkar (University of California San Francisco, USA) discusses her Comment on reproductive health in women with chronic liver disease.

Ola Olén discusses the assesment of colorectal cancer risk in patients with Crohn's disease.

Dr Akbar Waljee discusses findings from a cohort study investigating the risk of cancer recurrence or a new primary cancer in patients with IBD, rheumatoid arthritis, or psoriasis who received anti-TNFα therapy.

Dr Kushala Abeysekara discusses research looking at the prevalence of non-alcoholic fatty liver disease in young adults in England.

Professor Alexander Ford discusses a meta analysis comparing different traditional treatments for irritable bowel syndrome.

Dr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosis

Mohsen Naghavi describes the key findings from two new Global Burden of Disease studies investigating the global burden of pancreatic cancer and colorectal cancer.

Viktor Wintzell joins The Lancet Gastroenterology & Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.

Prof Raymond Chung discusses new research in transplantation of HCV-infected hearts.

Daniel Lambrichts joins The Lancet Gastroenterology & Hepatology to discuss different treatments for diverticulitis.

Dr Olga Aroniaidis discusses the results of a newly published trial of FMT to treat IBS.

Dr Eric Jelovsek discusses new research into the treatment of this important and often overlooked condition.

Philippa Easterbrook discusses a series of two Review articles on viral hepatitis in children and adolescents.

Stuart Taylor discusses the results of the STREAMLINE trials, which assessed the use of whole-body MRI to stage colorectal and lung cancers.

Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.

Bart Rijnders discusses his recent work on the treatment of people with acute hepatitis C.

Jennifer Flemming talks with The Lancet Gastroenterology & Hepatology about recent developments in the field of chronic liver disease.

Marc Rothenberg joins The Lancet Gastroenterology & Hepatology to talk about eosinophilic oesophagitis endotype classification.

Graham Foster speaks with The Lancet Gastroenterology & Hepatology about his recent work on incentivising and supporting primary-care physicians to increase hepatitis screenings of migrant populations.